IMCD Australia & New Zealand agree to acquire RPL Trading

ROTTERDAM: IMCD Australia & New Zealand have signed an agreement to acquire 100% of the shares of RPL Trading Pty Ltd and RPL Trading New Zealand Ltd. (jointly RPL Trading). “RPL Trading brings an excellent and highly complementary portfolio of suppliers, products, and customers to IMCD,” remarked Martin Stoemmer, Managing Director of IMCD Australia &…

MGC launches new Cannabinoid products line in Australia & New Zealand

PERTH, AUSTRALIA: MGC Pharmaceuticals Ltd announced the launch of a new proprietary affordable prescription medicine line to be branded as Mercury Pharma, specifically for the Australian and New Zealand markets. MGC is European based ‘Seed to Pharmacy’ bio-pharma company focused on developing and commercialising cannabinoid derived medicines. The first product being “Mercury Pharma 100” (MP100),…